XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.3
Investment in Cornerstone Pharmaceuticals (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
1 Months Ended 3 Months Ended
Jul. 31, 2022
Jun. 17, 2022
Oct. 01, 2021
Sep. 24, 2021
Oct. 31, 2023
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Principal amount (in Dollars)         $ 44.0
Ownership percentage in non-operating subsidiary         50.00%
Ownership interest percentage         8.00%
CS Pharma Holdings, LLC [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Indirect interest in assets held, percentage         45.00%
Rafael Pharmaceuticals [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Percentage of outstanding capital stock         51.00%
Percentage of outstanding capital stock on fully diluted basis         42.00%
Fully diluted         10.00%
Pharma Holdings, LLC [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Ownership percentage in non-operating subsidiary         90.00%
Ownership interest percentage         51.00%
Aggregate amount (in Dollars)       $ 25.0  
Agreement accrues interest per annum   9.00%      
Reserve amount (in Dollars) $ 25.0        
Series D Convertible Preferred Stock [Member] | CS Pharma Holdings, LLC [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Purchase of exercise the warrant, shares (in Shares)         16.7
Series D Preferred Stock [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Convertible preferred stock per share (in Dollars per share)         $ 1.25
Pharma Holdings, LLC [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Owned non-operating subsidiary         90.00%
CS Pharma Holdings, LLC [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Owned non-operating subsidiary         50.00%
Howard Jonas [Member] | Rafael Pharmaceuticals [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Fully diluted         10.00%
Howard Jonas [Member] | Pharma Holdings, LLC [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Owned non-operating subsidiary         10.00%
First Advance [Member] | Pharma Holdings, LLC [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Advance amount of debtor (in Dollars)       $ 1.9  
Second Advance [Member] | Pharma Holdings, LLC [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Advance amount of debtor (in Dollars)     $ 23.1    
Subsidiary Pharma Holdings [Member]          
Investment in Cornerstone Pharmaceuticals (Details) [Line Items]          
Held percentage         43.00%